Literature DB >> 12195008

Paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate.

A O Olukoga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12195008      PMCID： PMC1769751          DOI： 10.1136/jcp.55.9.718-a

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  5 in total

1.  Fibrate monotherapy and profound hypoalphalipoproteinaemia.

Authors:  A O Olukoga; V E Crowley; M F Stewart; O Weinkove
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

2.  Paradoxical high-density lipoprotein reduction induced by fenofibrate and ciprofibrate.

Authors:  P O Collinson; C J Hjelm; R Canepo-Anson
Journal:  Ann Clin Biochem       Date:  1996-03       Impact factor: 2.057

3.  A paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate.

Authors:  M A Crook; J Lynas; R Wray
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

Review 4.  Mechanism of action of fibrates on lipid and lipoprotein metabolism.

Authors:  B Staels; J Dallongeville; J Auwerx; K Schoonjans; E Leitersdorf; J C Fruchart
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

5.  Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response.

Authors:  N Hennuyer; P Poulain; L Madsen; R K Berge; L M Houdebine; D Branellec; J C Fruchart; C Fiévet; N Duverger; B Staels
Journal:  Circulation       Date:  1999-05-11       Impact factor: 29.690
  5 in total
  1 in total

1.  Paradoxical severe decrease in serum HDL-cholesterol after treatment with a fibrate: reply by the authors.

Authors:  M Crook; J Lynas; R Wray
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.